C.C. Engels

1.2k total citations
31 papers, 893 citations indexed

About

C.C. Engels is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, C.C. Engels has authored 31 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in C.C. Engels's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Bone Tumor Diagnosis and Treatments (5 papers). C.C. Engels is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Bone Tumor Diagnosis and Treatments (5 papers). C.C. Engels collaborates with scholars based in Netherlands, Germany and United States. C.C. Engels's co-authors include Gerrit‐Jan Liefers, G. Delling, Mathias Werner, Peter J.K. Kuppen, E. Kaiser, Cornelis J.�H. van de Velde, Hein Putter, Manuela Wülling, Esther Bastiaannet and Vincent T.H.B.M. Smit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and British Journal of Cancer.

In The Last Decade

C.C. Engels

30 papers receiving 879 citations

Peers

Countries citing papers authored by C.C. Engels

Since Specialization

Citations

This map shows the geographic impact of C.C. Engels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.C. Engels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.C. Engels more than expected).

Fields of papers citing papers by C.C. Engels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.C. Engels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.C. Engels. The network helps show where C.C. Engels may publish in the future.

Co-authorship network of co-authors of C.C. Engels

This figure shows the co-authorship network connecting the top 25 collaborators of C.C. Engels. A scholar is included among the top collaborators of C.C. Engels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.C. Engels. C.C. Engels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Resource use and in-hospital costs after aneurysmal subarachnoid hemorrhage in the Netherlands 2025 ·Brain and Spine ·(unknown), Jeroen T.J.M. van Dijck, (unknown), C.C. Engels, Wouter A. Moojen	0
2	Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy 2019 ·Breast Cancer Research and Treatment ·(unknown), Erik J. Blok, Ayoub Charehbili, C.C. Engels, Vincent T.H.B.M. Smit, (unknown), Hein Putter, Elma Meershoek‐Klein Kranenbarg, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers, J.W.R. Nortier, Peter J.K. Kuppen, Sjoerd H. van der Burg, Judith R. Kroep	18
3	Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer 2018 ·Breast Cancer Research and Treatment ·Erik J. Blok, C.C. Engels, (unknown), Elma Meershoek‐Klein Kranenbarg, Hein Putter, Vincent T.H.B.M. Smit, Gerrit‐Jan Liefers, James P. Morden, Judith M. Bliss, R. Charles Coombes, John M.S. Bartlett, Judith R. Kroep, Cornelis J.�H. van de Velde, Peter J.K. Kuppen	12
4	Targeted therapy in older women with breast cancer – What's the target? 2017 ·European Journal of Surgical Oncology ·M. Kiderlen, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers, Esther Bastiaannet, Anton J. M. de Craen, Peter J.K. Kuppen, W. van de Water, Nienke A. de Glas, Esther M. de Kruijf, C.C. Engels, (unknown), Marloes G.M. Derks	5
5	Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma 2017 ·Breast Cancer Research and Treatment ·(unknown), Gabi W. van Pelt, C.C. Engels, Hein Putter, Gerrit‐Jan Liefers, Vincent T.H.B.M. Smit, Rob A.�E.�M. Tollenaar, Peter J.K. Kuppen, Wilma E. Mesker	48
6	Tumour immune subtyping as a predictive biomarker for adjuvant endocrine therapy in early breast cancer 2016 ·Cancer Research ·Erik J. Blok, C.C. Engels, (unknown), (unknown), Judith R. Kroep, Peter J.K. Kuppen, Cornelis J.�H. van de Velde	1
7	The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis 2016 ·Breast Cancer Research and Treatment ·C.C. Engels, M. Kiderlen, Esther Bastiaannet, Ronald van Eijk, Antien L. Mooyaart, Vincent T.H.B.M. Smit, Anton J.M. de Craen, Peter J.K. Kuppen, Judith R. Kroep, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	9
8	The influence of insulin‐like Growth Factor‐1‐Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis 2015 ·Molecular Oncology ·C.C. Engels, Nienke A. de Glas, Anita Sajet, Esther Bastiaannet, Vincent T.H.B.M. Smit, Peter J.K. Kuppen, Caroline Seynaeve, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	12
9	Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified? 2015 ·Breast Cancer Research and Treatment ·Nienke A. de Glas, C.C. Engels, Esther Bastiaannet, W. van de Water, Sabine Siesling, Anton J. M. de Craen, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers, J. W. S. Merkus	8
10	Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression 2015 ·Journal of Thrombosis and Haemostasis ·Begüm Kocatürk, (unknown), Dianne Vreeken, (unknown), C.C. Engels, Esther M. de Kruijf, Peter J.K. Kuppen, Pieter H. Reitsma, Vladimir Y. Bogdanov, Henri H. Versteeg	16
11	The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis 2015 ·Breast Cancer Research and Treatment ·C.C. Engels, Ayoub Charehbili, Cornelis J.�H. van de Velde, Esther Bastiaannet, Anita Sajet, Hein Putter, Erwin A. van Vliet, Ronald L. P. van Vlierberghe, Vincent T.H.B.M. Smit, John M.S. Bartlett, Caroline Seynaeve, Gerrit‐Jan Liefers, Peter J.K. Kuppen	33
12	How does genome sequencing impact surgery? 2014 ·Nature Reviews Clinical Oncology ·Marlies S. Reimers, C.C. Engels, Peter J.K. Kuppen, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	11
13	Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma 2014 ·British Journal of Cancer ·C.C. Engels, D.B.Y. Fontein, Peter J.K. Kuppen, Esther M. de Kruijf, Vincent T.H.B.M. Smit, J.W.R. Nortier, Gerrit‐Jan Liefers, Cornelis J.�H. van de Velde, Esther Bastiaannet	15
14	Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study 2014 ·BMC Cancer ·Marlies S. Reimers, C.C. Engels, Hein Putter, Hans Morreau, Gerrit‐Jan Liefers, Cornelis JH van de Velde, Peter J.K. Kuppen	77
15	The prognostic value of apoptotic and proliferative markers in breast cancer 2013 ·Breast Cancer Research and Treatment ·C.C. Engels, (unknown), Esther M. de Kruijf, Gabi W. van Pelt, Vincent T.H.B.M. Smit, Gerrit‐Jan Liefers, Tomoko Matsushima, Masaki Shibayama, Hideki Ishihara, Cornelis J.�H. van de Velde, Peter J.K. Kuppen	22
16	Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients 2013 ·Breast Cancer Research and Treatment ·Esther M. de Kruijf, C.C. Engels, W. van de Water, Esther Bastiaannet, Vincent T.H.B.M. Smit, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers, Peter J.K. Kuppen	21
17	Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis 2013 ·Annals of Oncology ·M. Kiderlen, Nienke A. de Glas, Esther Bastiaannet, C.C. Engels, W. van de Water, Anton J. M. de Craen, Johanneke E.A. Portielje, Cornelis J.�H. van de Velde, Gerrit‐Jan Liefers	40
18	Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis 2004 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), Thorsten Klink, (unknown), C.C. Engels, Thomas Wagner	10
19	The nature of giant cell tumor of bone 2001 ·Journal of Cancer Research and Clinical Oncology ·Manuela Wülling, C.C. Engels, (unknown), Mathias Werner, G. Delling, E. Kaiser	147
20	Das Chondromyxoidfibrom 1999 ·Der Pathologe ·C.C. Engels, Matthias Priemel, (unknown), Mathias Werner, G. Delling	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact